Pre-Seed · TechBio · In-Silico Stage

A self-funding Enzyme-as-a-Service platform powering the circular polymer economy.

Engineering oxidative enzymes to crack the carbon-carbon bonds of Polyolefins (PP/PE) — the "un-recyclable" 91%.

460M
Tons / yr produced
91%
Sent to landfill
1,000x
Faster vs. legacy R&D
$3M
Pre-Seed target
Problem & Solution

A broken loop. A computational fix.

Polyolefins dominate global plastic — and almost none of them come back. Zymos closes the loop with AI-designed enzymes.

The Problem

The Polyolefin Crisis

460M tons of plastic produced annually, with 91% sent to landfills. Mechanical recycling is broken.

  • Carbon-carbon backbones resist hydrolytic enzymes.
  • Mechanical recycling degrades polymer quality every cycle.
  • Incumbent chemical recycling is energy-intensive & CapEx-heavy.
The Solution

The Enzyme Studio

Using ProteinMPNN and RFdiffusion to generate optimized sequences 1,000x faster than traditional R&D.

  • AI-designed oxidative enzymes targeting PP/PE backbones.
  • In-silico screening collapses years of bench work into weeks.
  • Outsourced CRO validation — zero CapEx, maximum velocity.
Business Model

The Dual-Track Flywheel

A self-funding engine: cash-flowing services on one track, IP-generating discovery on the other.

Track B

Audit & Rescue EaaS

Immediate, high-margin cash flow from computational dataset rescue services.

Capital Allocation

The R&D Firewall

10% gross revenue and 50% net profit automatically funneled to discovery.

Track A

The Virtual Lab

Zero-CapEx operations utilizing AI design and outsourced CRO validation.

Monetization

IP Licensing

High-margin upfront capacity fees coupled with recurring backend royalties.

Traction & Unit Economics

Engineered for capital efficiency.

Software-grade margins on a deeptech moat.

Audit Rate
$150/hr

Audit Rate for immediate Track B revenue.

Gross Margin
80–90%

Gross Margin powered by 0% VAT & optimized cloud compute.

Validation Cycle
<$30k

Virtual Lab Cycle cost for physical validation of 50 AI-designed variants.

The Ask

$3M Pre-Seed Round

Target: Validated Lead Candidate and Provisional Patent Application in 18 Months.

CRO Screening

Outsourced wet-lab validation of top variants.

Remote R&D Team

Senior computational biologists & ML engineers.

Scale-Up

Pilot reactor partnerships & IP filings.

Funds deployed to CRO screening, Remote R&D Team, and Scale-Up.

Founder & CEO
KM

Kurmanbek Mukhambetov

Founder & CEO · Zymos

Biomedical engineer (KSTU). Accelerate Prosperity Incubator Alumnus. Raised $14k & led 250+ people in previous venture. Top 5% Global Climate Science Olympiad.

  • Biomedical Eng., KSTU
  • Accelerate Prosperity Alum
  • $14k raised previously
  • Top 5% Climate Olympiad
mukhkurmanbek@gmail.com

Ready to dive into the deck?

Full thesis, market sizing, milestones, and unit economics.